Clinical Trial

Identifying High-Risk Breast Cancer Patients

Study Description

Combined Breast MRI and Biomarker Strategies in Identifying High-risk Breast Cancer Patients

This clinical trial studies normal breast tissue changes combined with breast magnetic resonance imaging (MRI) that may suggest the beginnings of cancer development. Using breast tissue markers in combination with breast imaging such as MRI may help to more accurately assess a woman's risk of developing breast cancer.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Procedure - Magnetic Resonance Imaging

Undergo high risk breast cancer screening MRI

Procedure - Biospecimen Collection

Undergo blood and tissue sample collection

Laboratory Biomarker Analysis

Correlative studies

Additional Information

Official Study Title

Combined Breast MRI/Biomarker Strategies to Identify Aggressive Biology

Clinical Trial ID

NCT03303846

ParticipAid ID

Le3Nrd